These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 22492501

  • 1. Daily parathyroid hormone 1-34 replacement therapy for hypoparathyroidism induces marked changes in bone turnover and structure.
    Gafni RI, Brahim JS, Andreopoulou P, Bhattacharyya N, Kelly MH, Brillante BA, Reynolds JC, Zhou H, Dempster DW, Collins MT.
    J Bone Miner Res; 2012 Aug; 27(8):1811-20. PubMed ID: 22492501
    [Abstract] [Full Text] [Related]

  • 2. PTH(1-84) administration reverses abnormal bone-remodeling dynamics and structure in hypoparathyroidism.
    Rubin MR, Dempster DW, Sliney J, Zhou H, Nickolas TL, Stein EM, Dworakowski E, Dellabadia M, Ives R, McMahon DJ, Zhang C, Silverberg SJ, Shane E, Cremers S, Bilezikian JP.
    J Bone Miner Res; 2011 Nov; 26(11):2727-36. PubMed ID: 21735476
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Therapy of hypoparathyroidism with intact parathyroid hormone.
    Rubin MR, Sliney J, McMahon DJ, Silverberg SJ, Bilezikian JP.
    Osteoporos Int; 2010 Nov; 21(11):1927-34. PubMed ID: 20094706
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Treatment with human parathyroid hormone (1-34) for 18 months increases cancellous bone volume and improves trabecular architecture in ovariectomized cynomolgus monkeys (Macaca fascicularis).
    Jerome CP, Burr DB, Van Bibber T, Hock JM, Brommage R.
    Bone; 2001 Feb; 28(2):150-9. PubMed ID: 11182372
    [Abstract] [Full Text] [Related]

  • 11. Effects of a one-month treatment with PTH(1-34) on bone formation on cancellous, endocortical, and periosteal surfaces of the human ilium.
    Lindsay R, Zhou H, Cosman F, Nieves J, Dempster DW, Hodsman AB.
    J Bone Miner Res; 2007 Apr; 22(4):495-502. PubMed ID: 17227219
    [Abstract] [Full Text] [Related]

  • 12. Therapy of Hypoparathyroidism With PTH(1-84): A Prospective Six Year Investigation of Efficacy and Safety.
    Rubin MR, Cusano NE, Fan WW, Delgado Y, Zhang C, Costa AG, Cremers S, Dworakowski E, Bilezikian JP.
    J Clin Endocrinol Metab; 2016 Jul; 101(7):2742-50. PubMed ID: 27144931
    [Abstract] [Full Text] [Related]

  • 13. Skeletal changes after restoration of the euparathyroid state in patients with hypoparathyroidism and primary hyperparathyroidism.
    Cipriani C, Abraham A, Silva BC, Cusano NE, Rubin MR, McMahon DJ, Zhang C, Hans D, Silverberg SJ, Bilezikian JP.
    Endocrine; 2017 Feb; 55(2):591-598. PubMed ID: 27757772
    [Abstract] [Full Text] [Related]

  • 14. Histomorphometric evidence for increased bone turnover without change in cortical thickness or porosity after 2 years of cyclical hPTH(1-34) therapy in women with severe osteoporosis.
    Hodsman AB, Kisiel M, Adachi JD, Fraher LJ, Watson PH.
    Bone; 2000 Aug; 27(2):311-8. PubMed ID: 10913928
    [Abstract] [Full Text] [Related]

  • 15. Effects of cyclic vs. daily treatment with human parathyroid hormone (1-34) on murine bone structure and cellular activity.
    Iida-Klein A, Lu SS, Cosman F, Lindsay R, Dempster DW.
    Bone; 2007 Feb; 40(2):391-8. PubMed ID: 17056311
    [Abstract] [Full Text] [Related]

  • 16. Skeletal actions of intermittent parathyroid hormone: effects on bone remodelling and structure.
    Compston JE.
    Bone; 2007 Jun; 40(6):1447-52. PubMed ID: 17045858
    [Abstract] [Full Text] [Related]

  • 17. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone.
    Duan Y, De Luca V, Seeman E.
    J Clin Endocrinol Metab; 1999 Feb; 84(2):718-22. PubMed ID: 10022443
    [Abstract] [Full Text] [Related]

  • 18. The skeleton in primary hyperparathyroidism: a review focusing on bone remodeling, structure, mass, and fracture.
    Christiansen P.
    APMIS Suppl; 2001 Feb; (102):1-52. PubMed ID: 11419022
    [Abstract] [Full Text] [Related]

  • 19. Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium.
    Winer KK, Sinaii N, Reynolds J, Peterson D, Dowdy K, Cutler GB.
    J Clin Endocrinol Metab; 2010 Jun; 95(6):2680-8. PubMed ID: 20392870
    [Abstract] [Full Text] [Related]

  • 20. Effects of daily treatment with parathyroid hormone on bone microarchitecture and turnover in patients with osteoporosis: a paired biopsy study.
    Dempster DW, Cosman F, Kurland ES, Zhou H, Nieves J, Woelfert L, Shane E, Plavetić K, Müller R, Bilezikian J, Lindsay R.
    J Bone Miner Res; 2001 Oct; 16(10):1846-53. PubMed ID: 11585349
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.